Catalyst Event
Celltrion Inc (068270) · Other
From Akros Korea Shareholder Return High Dividend Index (AKSRHD)
3/16/2026, 12:00:00 AM
Announced on March 16, 2026, that its tocilizumab biosimilar, AVTOZMA®, is now commercially available in the United States. This launch is estimated to have a price impact of 1% or more, scheduled.
Korean Translation
2026년 3월 16일 '압토즈마'의 미국 시장 출시를 발표함. 1% 이상의 주가 영향이 예상되며 예정됨.
Related Recent Events
Samsung Card Co Ltd (029780) · Earnings Release
Samsung Card is expected to announce its Q1 2026 earnings results on April 28, 2026, as financial data providers forecast. Market impact is estimated at ~1% based on typical quarterly earnings volatility forecasted.
4/28/2026, 12:00:00 AM
Korean Reinsurance Company (003690) · Other
Cancellation of 18.1 million treasury shares on 2026-03-31, which is estimated to result in a price impact of over 10% as analysts forecasted, is scheduled.
3/31/2026, 12:00:00 AM
COWAY Co Ltd (021240) · Other
A proxy fight with activist fund Align Partners over board appointments at the Annual General Meeting on March 31, 2026, with an estimated price impact of ≥5% due to governance uncertainty, is expected.
3/31/2026, 12:00:00 AM
NH Investment & Securities Co Ltd (005940) · Other
The ex-dividend date for the FY 2025 annual dividend of KRW 1,300 per common share on March 30, 2026, for which high importance is estimated due to the significant 36.8% increase in payout, scheduled.
3/30/2026, 12:00:00 AM
Shin Young Securities Co Ltd (001720) · Other
Annual dividend of KRW 5,000 per share for the fiscal year ending March 2026. The ex-dividend date is March 30, 2026. This high dividend yield is estimated to have a 5% price impact, scheduled.
3/30/2026, 12:00:00 AM
Korean Reinsurance Company (003690) · Other
The Annual General Meeting of Shareholders on 2026-03-27, which is estimated to have a price impact of at least 1% due to governance concerns as analysts forecasted, is scheduled.
3/27/2026, 12:00:00 AM